Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Ambu

Ylin-
Alin-
Vaihto-
2026 Q4 - tulosraportti
11 päivää sitten
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMäärä
54
438
338
14
571

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q1 - tulosraportti
28.1.2027
Menneet tapahtumat
2026 Q4 - tulosraportti
5.11.
2026 Q3 - tulosraportti
26.8.
2026 Q2 - tulosraportti
6.5.
2026 Q1 - tulosraportti
4.2.
2025 Q4 - tulosraportti
5.11.2025

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Käyttäjän profiilikuva
    2 t sitten · Muokattu
    ·
    The buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
  • Käyttäjän profiilikuva
    3 päivää sitten
    Short squeeze!?
    Käyttäjän profiilikuva
    5 t sitten · Muokattu
    ·
    ....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Hard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?
    Käyttäjän profiilikuva
    2 päivää sitten
    ·
    Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Is there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekend
    Käyttäjän profiilikuva
    4 t sitten
    ·
    input from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Käyttäjän profiilikuva
    3 päivää sitten
    ·
    til 93 :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600
2026 Q4 - tulosraportti
11 päivää sitten
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Käyttäjän profiilikuva
    2 t sitten · Muokattu
    ·
    The buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
  • Käyttäjän profiilikuva
    3 päivää sitten
    Short squeeze!?
    Käyttäjän profiilikuva
    5 t sitten · Muokattu
    ·
    ....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Hard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?
    Käyttäjän profiilikuva
    2 päivää sitten
    ·
    Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Is there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekend
    Käyttäjän profiilikuva
    4 t sitten
    ·
    input from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Käyttäjän profiilikuva
    3 päivää sitten
    ·
    til 93 :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMäärä
54
438
338
14
571

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q1 - tulosraportti
28.1.2027
Menneet tapahtumat
2026 Q4 - tulosraportti
5.11.
2026 Q3 - tulosraportti
26.8.
2026 Q2 - tulosraportti
6.5.
2026 Q1 - tulosraportti
4.2.
2025 Q4 - tulosraportti
5.11.2025

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600
2026 Q4 - tulosraportti
11 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2027 Q1 - tulosraportti
28.1.2027
Menneet tapahtumat
2026 Q4 - tulosraportti
5.11.
2026 Q3 - tulosraportti
26.8.
2026 Q2 - tulosraportti
6.5.
2026 Q1 - tulosraportti
4.2.
2025 Q4 - tulosraportti
5.11.2025
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Käyttäjän profiilikuva
    2 t sitten · Muokattu
    ·
    The buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
  • Käyttäjän profiilikuva
    3 päivää sitten
    Short squeeze!?
    Käyttäjän profiilikuva
    5 t sitten · Muokattu
    ·
    ....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Hard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?
    Käyttäjän profiilikuva
    2 päivää sitten
    ·
    Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Is there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekend
    Käyttäjän profiilikuva
    4 t sitten
    ·
    input from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
  • Käyttäjän profiilikuva
    3 päivää sitten
    ·
    Käyttäjän profiilikuva
    3 päivää sitten
    ·
    til 93 :-)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMäärä
54
438
338
14
571

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi359 766359 76600
© 2026 Nordnet Bank AB.
Nordnet | Alvar Aallon katu 5 C, 3. krs | FI-00100 Helsinki